ZDA
AGN

Zweig-DiMenna Associates’s Allergan Inc AGN Stock Holding History

Zweig-DiMenna Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-370,471
Closed -$78.8M – 359
2014
Q4 		$78.8M Buy
370,471
+46,310
+14% +$9.21M 3.39% 1
2014
Q3 		$57.8M Buy
324,161
+17,453
+6% +$2.9M 2.53% 5
2014
Q2 		$51.9M Buy
+306,708
New +$47.8M 2.37% 7
2014
Q1 		– Sell
-87,410
Closed -$9.71M – 344
2013
Q4 		$9.71M Hold
87,410
– – 0.36% 92
2013
Q3 		$7.91M Hold
87,410
– – 0.32% 110
2013
Q2 		$7.36M Buy
+87,410
New +$9.07M 0.3% 107

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Zweig-DiMenna Associates's AGN Position: Q1 2015 in Review

Zweig-DiMenna Associates sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 370,471 shares — an estimated $78.8M sold.

Zweig-DiMenna Associates first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $78.8M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Zweig-DiMenna Associates reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 370,471 Allergan Inc shares in Q1 2015, an estimated $78.8M.
  • Zweig-DiMenna Associates first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Zweig-DiMenna Associates's Allergan Inc position peaked at $78.8M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2015, filed 11 May 2015.